PRTK — Paratek Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall Cap

Annual balance sheet for Paratek Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	250	215	125	95.5	34.2
Net Total Accounts Receivable
Net Total Receivables	0.249	9.58	15.7	33.1	78
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	255	243	164	152	137
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.17	3.74	2.97	2.55	2.4
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	300	251	177	184	173
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.7	24.2	24	31.3	37.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	253	291	279	312	344
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	47.6	-39.6	-102	-128	-171
Total Liabilities & Shareholders' Equity	300	251	177	184	173
Total Common Shares Outstanding